Table 1.
Parameter | Capsule endoscopy first | MR enteroclysis first | Total study group | P value |
---|---|---|---|---|
Number of patients, n | 61 | 16 | 77 | |
Female/male, n | 28/33 | 7/9 | 35/42 | 0.878a |
Mean age, y (SD) | 51 (20) | 50 (19) | 51 (19) | 0.887b |
Main indication, n (%) | 0.180c | |||
Suspected MGIB | 30 (49.2) | 4 (25.0) | 34 (44.2) | |
Polyposis syndrome | 10 (16.4) | 4 (25.0) | 14 (18.2) | |
Suspected refractory celiac disease | 10 (16.4) | 1 (6.3) | 11 (14.3) | |
Abdominal pain | 5 (8.2) | 2 (12.5) | 7 (9.1) | |
Malabsorption | 3 (4.9) | 3 (18.8) | 6 (7.8) | |
Crohn’s disease | 3 (4.9) | 2 (12.5) | 5 (6.5) | |
Mean duration of clinical follow-up, y (SD) | 42 (17) | 38 (16) | 40 (17) | 0.476b |
MGIB, midgastrointestinal bleeding; DBE, double-balloon endoscopy
a Calculated with the two-sided Student t test
b Calculated with Fishers exact test
c Calculated with the Chi-square test